SMS Pharmaceuticals Ltd

SMSPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,103 cr, stock is ranked 922
Moderate RiskStock is 2.65x as volatile as Nifty
130.301.10 (+0.85%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,103 cr, stock is ranked 922
Moderate RiskStock is 2.65x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
17.65
PB RatioPB Ratio
2.69
Dividend YieldDiv. Yield
0.23%
Sector PESector PE
38.74
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SMS Pharmaceuticals Limited is engaged in manufacturing and sale of bulk drugs and active pharmaceutical ingredients (APIs), and their intermediates.

Investor PresentationView older 

Nov 13, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021465.07468.31417.06566.6231.7740.0431.5762.51
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnNov 25, 2021

SMS Pharmaceuticals Limited has informed the Exchange regarding 'intimation of schedule of Analyst / Institutional investor meetings under SEBI (LODR) Regulations, 2015'. | Download

SMS Pharmaceuticals Limited has informed the Exchange regarding 'intimation of schedule of Analyst / Institutional investor meetings under SEBI (LODR) Regulations, 2015'. | Download

Updates 
Announced OnNov 23, 2021

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call Transcript Q2 FY22'. | Download

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call Transcript Q2 FY22'. | Download

Cash Dividend 
Ex. DateSep 22, 2021

Final • Div/Share: ₹ 0.3

See all events